Related Experiment Videos
Quantitative Immunological study of pregnancy-associated alpha2-globulin antigen
Vox Sanguinis
|January 1, 1976
Summary
Pregnancy-associated alpha2-globulin antigen levels increase during pregnancy, peaking at 31 weeks. Lower levels are seen in prolonged pregnancies, while elevated amounts may indicate tumors.
Area of Science:
- Biochemistry
- Immunology
- Reproductive Biology
Background:
- Pregnancy-associated alpha2-globulin (PAAG) is a serum protein with minimal levels in nonpregnant individuals.
- PAAG levels exhibit dynamic changes throughout gestation.
Purpose of the Study:
- To investigate the quantitative changes of PAAG during pregnancy.
- To explore the correlation of PAAG levels with pregnancy complications and tumor presence.
Main Methods:
- Serum samples were collected from pregnant individuals at various gestational stages.
- Quantitative analysis of PAAG was performed.
Main Results:
- PAAG levels gradually increased, reaching a peak of 96 +/- 44 mg% around the 31st week of gestation.
- A decline to 65 +/- 30 mg% was observed in the final two months before delivery.
- Significantly lower PAAG levels were detected in cases of prolonged pregnancy and abortions with placental destruction.
- Elevated PAAG levels were found in 63% of 100 analyzed tumor patients.
Conclusions:
- PAAG serves as a characteristic pregnancy protein with predictable gestational dynamics.
- Abnormal PAAG levels may indicate pregnancy complications or the presence of tumors.